发明名称 FGL-2 prothrombinase as a diagnostic tool for malignancy
摘要 The present invention reveals a strong correlation between FGL-2 prothrombinase activity levels and the presence of a malignant proliferative disorder in a subject. Thus, the present invention provides FGL-2 prothrombinase activity as a diagnostic tool for malignancy.
申请公布号 US9023609(B2) 申请公布日期 2015.05.05
申请号 US201113809697 申请日期 2011.07.11
申请人 Mor Research Applications Ltd.;Ramot at Tel-Aviv University Ltd. 发明人 Inbal Aida;Rabizadeh Esther
分类号 C12Q1/37;G01N33/574 主分类号 C12Q1/37
代理机构 Marsteller & Associates, P.C. 代理人 Marsteller & Associates, P.C.
主权项 1. A method for the diagnosis of a malignant proliferative disorder in a subject, said method comprising the steps of: (a) collecting a blood sample from said subject and a blood sample from a normal control; (b) isolating peripheral blood mononuclear cells (PBMC) from said samples; (c) measuring prothrombinase activity in the PBMC from said samples, using a thrombin generation assay, comprising generating thrombin from added prothrombin and determining the thrombin by using a chromogenic substrate; and; (d) comparing the prothrombinase activity of the PBMC from said subject with the prothrombinase activity from said control;whereby a sample with prothrombinase activity higher than control is indicative of the presence of a malignant disorder in said subject.
地址 Tel Aviv IL